Abstract:The E-26 transforming specific (ETS)-related gene, TEL, also known as ETV6, encodes a strong transcription repressor that is rearranged in several recurring chromosomal rearrangements associated with leukemia and congenital fibrosarcoma. TEL is a nuclear phosphoprotein that is widely expressed in all normal tissues. TEL contains a DNA-binding domain at the C terminus and a helixloop-helix domain (also called a pointed domain) at the N terminus. The pointed domain is necessary for homotypic dimerization and for… Show more
“…SUMO modification appears to play a role in a variety of cellular processes including protein-protein interaction, subcellular localization, protein stabilization and transcriptional regulation (Dohmen, 2004). A large number of SUMO target proteins have been identified, including several members of the Ets transcription factors family (Chakrabarti et al, 2000;Yang et al, 2003;Degerny et al, 2005;Leight et al, 2005;van den Akker et al, 2005;Wasylyk et al, 2005). Recently, we reported that the ERM Ets protein is sumoylated and that sumoylation of ERM represses its transcriptional activity (Degerny et al, 2005).…”
Sumoylation and ubiquitinylation reversibly regulate the activity of transcription factors through covalent attachment to lysine residues of target proteins. We examined whether the Ets-1 transcription factor is modified by sumoylation and/or ubiquitinylation. Among four potential SUMO motifs in Ets-1, we identified lysines 15 and 227 within the LK 15 YE and IK 227 QE motifs, as being the sumoylation acceptor sites. Using transfection of Ets-1 wildtype (WT) or its sumoylation deficient version (Ets-1 K15R/K227R), as well as WT or mutant proteins of the SUMO pathway, we further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation, while a SUMO protease, SENP1, can desumoylate Ets-1. We also found that Ets-1 is modified by K48-linked polyubiquitinylation independently of the sumoylation acceptor sites and is degraded through the 26S proteasome pathway, while sumoylation of Ets-1 does not affect its stability. Finally, sumoylation of Ets-1 leads to reduced transactivation and we demonstrated that previously identified critical lysine residues in Synergistic Control motifs are the sumoylation acceptor sites of Ets-1. These data show that Ets-1 can be modified by sumoylation and/or ubiquitinylation, with sumoylation repressing transcriptional activity of Ets-1 and having no clear antagonistic action on the ubiquitin-proteasome degradation pathway.
“…SUMO modification appears to play a role in a variety of cellular processes including protein-protein interaction, subcellular localization, protein stabilization and transcriptional regulation (Dohmen, 2004). A large number of SUMO target proteins have been identified, including several members of the Ets transcription factors family (Chakrabarti et al, 2000;Yang et al, 2003;Degerny et al, 2005;Leight et al, 2005;van den Akker et al, 2005;Wasylyk et al, 2005). Recently, we reported that the ERM Ets protein is sumoylated and that sumoylation of ERM represses its transcriptional activity (Degerny et al, 2005).…”
Sumoylation and ubiquitinylation reversibly regulate the activity of transcription factors through covalent attachment to lysine residues of target proteins. We examined whether the Ets-1 transcription factor is modified by sumoylation and/or ubiquitinylation. Among four potential SUMO motifs in Ets-1, we identified lysines 15 and 227 within the LK 15 YE and IK 227 QE motifs, as being the sumoylation acceptor sites. Using transfection of Ets-1 wildtype (WT) or its sumoylation deficient version (Ets-1 K15R/K227R), as well as WT or mutant proteins of the SUMO pathway, we further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation, while a SUMO protease, SENP1, can desumoylate Ets-1. We also found that Ets-1 is modified by K48-linked polyubiquitinylation independently of the sumoylation acceptor sites and is degraded through the 26S proteasome pathway, while sumoylation of Ets-1 does not affect its stability. Finally, sumoylation of Ets-1 leads to reduced transactivation and we demonstrated that previously identified critical lysine residues in Synergistic Control motifs are the sumoylation acceptor sites of Ets-1. These data show that Ets-1 can be modified by sumoylation and/or ubiquitinylation, with sumoylation repressing transcriptional activity of Ets-1 and having no clear antagonistic action on the ubiquitin-proteasome degradation pathway.
“…The SAM domain of PcG proteins mediates the interaction with UBC-9, leading to sumoylation, and directs the formation of subnuclear bodies whose characteristics are correlated with physiological function. Sumoylation itself has a variety of effects on its targets in cultured cells, including regulating the subnuclear localization of PML, HIPK2 and TEL [14][15][16] and modulating the transactivational activity of Sp3 and LEF1 (refs. 6,17).…”
Section: Sop-2(ph Sammentioning
confidence: 99%
“…Thus, intrinsic properties of the SAM domain may regulate the characteristics of nuclear body formation. The preferential sumoylation site in TEL, Lys99, is located within the SAM domain 14 , whereas the SAM domains of SOP-2 and PcG proteins lack the corresponding lysine residue and the sumoylated sites in SOP-2 seem to be outside the SAM domain (data not shown). To determine whether the distinct nuclear bodies formed in SOP-2(TEL SAM)::GFP were due to this sumoylation site, we mutated the TEL Lys99 to arginine within the chimeric construct.…”
mentioning
confidence: 96%
“…Phylogenetic analysis indicates that the SAM domain of SOP-2 belongs to a new nematode-specific SAM domain subfamily, which also includes the SAM domain of K04C1.2 and is more closely related to the SAM/PNT than to the SPM subfamiliy 3 . Nonetheless, the crystal structure shows that the SAM domains of PH and TEL form identical head-to-tail, left-handed helical polymers 12,13 , and the SAM domain of TEL is also required for its binding to UBC-9 and localization to nuclear bodies 14 . To correlate the functional properties of these SAM domains with their effects on nuclear localization, we undertook a series of domain-swapping experiments.…”
Figure 1Interaction of SOP-2 with UBC-9 and sumoylation. (a) Results of yeast two-hybrid screens using the C terminus of SOP-2 as bait. The strength of the protein interaction is graded on the basis of comparison with controls: human Rb and E2F-1 interaction (+, faint blue color after 24 h in X-gal assay) and rat c-Fos and mouse c-Jun interaction (+++, blue color within 1 h in X-gal assay). (b) Interaction of the wild-type SOP-2 SAM domain with itself, with the SOP-2(bx91) mutant protein and with UBC-9. The bx91 mutation substantially reduces its interaction with UBC-9 but not with the wild-type SOP-2 SAM domain. (c) In vitro and in vivo sumoylation of SOP-2. In vitro sumoylation was carried out using labeled SOP-2 and purified sumoylation components. In vivo sumoylation of hemagglutinin-tagged SOP-2 and the SOP-2(bx91) mutant was done after transfection and expression in mammalian U2OS cells. Cell lysates were analyzed by immunoprecipitation (IP) with antibody to SUMO and western blotting with antibody to hemagglutinin.
“…SUMO-1 modulates the interaction of the target protein with other cellular proteins and often results in changing the protein's location [9,27,43]. For example, a SUMO-attached protein may be transported to the nucleus [27,39].…”
Section: Upregulation Of Ubiquitin and Sumo Gene Families In The Pfc mentioning
Previously, we used cDNA microarrays to demonstrate that the phosphatidylinositol and MAP kinase signaling pathways are regulated by nicotine in different rat brain regions. In the present report, we show that, after exposure to nicotine for 14 days, ubiquitin, ubiquitinconjugating enzymes, 20S and 19S proteasomal subunits, and chaperonin-containing TCP-1 protein (CCT) complex members are upregulated in rat prefrontal cortex (PFC) while being downregulated in the medial basal hypothalamus (MBH). In particular, relative to saline controls, ubiquitins B and C were upregulated by 33% and 47% ( Pb0.01), respectively, in the PFC. The proteasome beta subunit 1 (PSMB1) and 26S ATPase 3 (PSMC3) genes were upregulated in the PFC by 95% and 119% ( Pb0.001), respectively. In addition to the protein degradation pathway of the ubiquitin-proteasome complexes, we observed in the PFC an increase in the expression of small, ubiquitin-related modifiers (SUMO) 1 and 2 by 80% and 33%, respectively ( Pb0.001), and in 3 of 6 CCT subunits by up to 150% ( Pb0.0001). To a lesser extent, a change in the opposite direction was obtained in the expression of the same gene families in the MBH. Quantitative real-time RT-PCR was used to validate the microarray results obtained with some representative genes involved in these pathways. Taken together, our results suggest that, in response to systemic nicotine administration, the ubiquitin-proteasome, SUMO, and chaperonin complexes provide an intricate control mechanism to maintain cellular homeostasis, possibly by regulating the composition and signaling of target neurons in a region-specific manner. D
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.